Q32 Bio Stock Performance
| QTTB Stock | 3.99 0.02 0.50% |
Q32 Bio holds a performance score of 7 on a scale of zero to a hundred. The firm owns a Beta (Systematic Risk) of -0.57, which implies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Q32 Bio are expected to decrease at a much lower rate. During the bear market, Q32 Bio is likely to outperform the market. Use Q32 Bio value at risk, daily balance of power, and the relationship between the total risk alpha and expected short fall , to analyze future returns on Q32 Bio.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Q32 Bio are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating basic indicators, Q32 Bio sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (0.50) | Five Day Return (1.24) | Year To Date Return 15.99 | Ten Year Return (98.81) | All Time Return (98.81) |
Last Split Factor 1:18 | Last Split Date 2024-03-26 |
1 | Q32 Bio Inc. stock trendline breakdown - Rate Cut Expert Curated Trade Setup Alerts - newser.com | 10/29/2025 |
2 | Q32 Bio Inc. Short Interest Update | 11/03/2025 |
3 | Is Q32 Bio Inc. stock reversal real or fake - 2025 Pullback Review Scalable Portfolio Growth Methods - newser.com | 11/11/2025 |
4 | Q32 Bio Reports Third Quarter 2025 Financial Results and Provides Corporate Update | 11/13/2025 |
5 | Crude Oil Gains Over 1 ISM Manufacturing PMI Falls In November | 12/01/2025 |
6 | Disposition of 9072 shares by Kalowski Lee of Q32 Bio at 3.4607 subject to Rule 16b-3 | 12/02/2025 |
7 | Acquisition by Manke Isaac of 53521 shares of Q32 Bio at 2.8 subject to Rule 16b-3 | 12/16/2025 |
8 | Q32 Bio Retains Mark Iwicki as Board Chair - TipRanks | 12/19/2025 |
9 | Market Review Will Q32 Bio Inc benefit from geopolitical trends - Weekly Stock Recap Community Shared Stock Ideas - baoquankhu1.vn | 01/21/2026 |
| Begin Period Cash Flow | 31.3 M | |
| Total Cashflows From Investing Activities | 19.9 M |
Q32 Bio Relative Risk vs. Return Landscape
If you would invest 276.00 in Q32 Bio on October 30, 2025 and sell it today you would earn a total of 123.00 from holding Q32 Bio or generate 44.57% return on investment over 90 days. Q32 Bio is currently generating 1.0403% in daily expected returns and assumes 10.7397% risk (volatility on return distribution) over the 90 days horizon. In different words, 96% of stocks are less volatile than Q32, and 80% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Q32 Bio Target Price Odds to finish over Current Price
The tendency of Q32 Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 3.99 | 90 days | 3.99 | nearly 4.95 |
Based on a normal probability distribution, the odds of Q32 Bio to move above the current price in 90 days from now is nearly 4.95 (This Q32 Bio probability density function shows the probability of Q32 Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Q32 Bio has a beta of -0.57 indicating as returns on the benchmark increase, returns on holding Q32 Bio are expected to decrease at a much lower rate. During a bear market, however, Q32 Bio is likely to outperform the market. Moreover Q32 Bio has an alpha of 1.0527, implying that it can generate a 1.05 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Q32 Bio Price Density |
| Price |
Predictive Modules for Q32 Bio
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Q32 Bio. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Q32 Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Q32 Bio Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Q32 Bio is not an exception. The market had few large corrections towards the Q32 Bio's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Q32 Bio, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Q32 Bio within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 1.05 | |
β | Beta against Dow Jones | -0.57 | |
σ | Overall volatility | 0.60 | |
Ir | Information ratio | 0.09 |
Q32 Bio Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Q32 Bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Q32 Bio can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Q32 Bio is way too risky over 90 days horizon | |
| Q32 Bio appears to be risky and price may revert if volatility continues | |
| Q32 Bio has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (47.73 M) with loss before overhead, payroll, taxes, and interest of (26.39 M). | |
| Q32 Bio generates negative cash flow from operations | |
| About 64.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: Travel Stocks Will VRTX announce a stock split - Stock Surge Short-Term Trading Alerts - baoquankhu1.vn |
Q32 Bio Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Q32 Stock often depends not only on the future outlook of the current and potential Q32 Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Q32 Bio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 12.2 M | |
| Cash And Short Term Investments | 78 M |
Q32 Bio Fundamentals Growth
Q32 Stock prices reflect investors' perceptions of the future prospects and financial health of Q32 Bio, and Q32 Bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Q32 Stock performance.
| Return On Equity | -4.92 | ||||
| Return On Asset | -0.33 | ||||
| Current Valuation | 17.33 M | ||||
| Shares Outstanding | 12.3 M | ||||
| Price To Book | 3.55 X | ||||
| Gross Profit | (26.39 M) | ||||
| EBITDA | (45.3 M) | ||||
| Net Income | (47.73 M) | ||||
| Total Debt | 18.9 M | ||||
| Book Value Per Share | (1.50) X | ||||
| Cash Flow From Operations | (67.72 M) | ||||
| Earnings Per Share | (3.40) X | ||||
| Market Capitalization | 49.09 M | ||||
| Total Asset | 92.33 M | ||||
| Retained Earnings | (234.81 M) | ||||
| Working Capital | 65.41 M | ||||
About Q32 Bio Performance
By analyzing Q32 Bio's fundamental ratios, stakeholders can gain valuable insights into Q32 Bio's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Q32 Bio has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Q32 Bio has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.59) | (0.62) | |
| Return On Capital Employed | (1.00) | (1.05) | |
| Return On Assets | (0.59) | (0.62) | |
| Return On Equity | (9.67) | (9.19) |
Things to note about Q32 Bio performance evaluation
Checking the ongoing alerts about Q32 Bio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Q32 Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Q32 Bio is way too risky over 90 days horizon | |
| Q32 Bio appears to be risky and price may revert if volatility continues | |
| Q32 Bio has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (47.73 M) with loss before overhead, payroll, taxes, and interest of (26.39 M). | |
| Q32 Bio generates negative cash flow from operations | |
| About 64.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: Travel Stocks Will VRTX announce a stock split - Stock Surge Short-Term Trading Alerts - baoquankhu1.vn |
- Analyzing Q32 Bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Q32 Bio's stock is overvalued or undervalued compared to its peers.
- Examining Q32 Bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Q32 Bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Q32 Bio's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Q32 Bio's stock. These opinions can provide insight into Q32 Bio's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Q32 Stock analysis
When running Q32 Bio's price analysis, check to measure Q32 Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Q32 Bio is operating at the current time. Most of Q32 Bio's value examination focuses on studying past and present price action to predict the probability of Q32 Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Q32 Bio's price. Additionally, you may evaluate how the addition of Q32 Bio to your portfolios can decrease your overall portfolio volatility.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |